SG149070A1 - Non-nucleotide reverse transcriptase inhibitors - Google Patents

Non-nucleotide reverse transcriptase inhibitors

Info

Publication number
SG149070A1
SG149070A1 SG200809639-8A SG2008096398A SG149070A1 SG 149070 A1 SG149070 A1 SG 149070A1 SG 2008096398 A SG2008096398 A SG 2008096398A SG 149070 A1 SG149070 A1 SG 149070A1
Authority
SG
Singapore
Prior art keywords
reverse transcriptase
transcriptase inhibitors
nucleotide reverse
nucleotide
inhibitors
Prior art date
Application number
SG200809639-8A
Other languages
English (en)
Inventor
Christian Sund
Nathalie Roue
Stefan Lindstroem
Dmitry Antonov
Christer Sahlberg
Katarina Jansson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0400021A external-priority patent/SE0400021D0/xx
Priority claimed from SE0400585A external-priority patent/SE0400585D0/xx
Application filed by Medivir Ab filed Critical Medivir Ab
Publication of SG149070A1 publication Critical patent/SG149070A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG200809639-8A 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors SG149070A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0400021A SE0400021D0 (sv) 2004-01-08 2004-01-08 Non-nucleoside reverse transcriptase inhibitors
SE0400585A SE0400585D0 (sv) 2004-03-09 2004-03-09 NNRTI Antivirals

Publications (1)

Publication Number Publication Date
SG149070A1 true SG149070A1 (en) 2009-01-29

Family

ID=34752289

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200809639-8A SG149070A1 (en) 2004-01-08 2004-12-30 Non-nucleotide reverse transcriptase inhibitors

Country Status (15)

Country Link
US (1) US7915295B2 (fr)
EP (1) EP1701942B1 (fr)
JP (1) JP4762917B2 (fr)
AT (1) ATE451357T1 (fr)
AU (1) AU2004312284B2 (fr)
BR (1) BRPI0418306B8 (fr)
CA (1) CA2550187C (fr)
DE (1) DE602004024584D1 (fr)
DK (1) DK1701942T3 (fr)
EA (1) EA009700B1 (fr)
ES (1) ES2337794T3 (fr)
IL (1) IL176740A (fr)
NZ (1) NZ548367A (fr)
SG (1) SG149070A1 (fr)
WO (1) WO2005066131A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1534276B1 (fr) * 2002-09-05 2008-11-05 Medivir AB Inhibiteurs de la transcriptase inverse non nucleosidiques
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
WO2006114001A1 (fr) * 2005-04-27 2006-11-02 Ambrilia Biopharma Inc. Procede d'amelioration de la pharmacocinetique d'inhibiteurs de protease et de leurs precurseurs
ES2452718T3 (es) 2005-11-30 2014-04-02 Taimed Biologics, Inc. Profármacos a base de lisina de inhibidores de la aspartil proteasa y procesos para su preparación
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
EP2021327B1 (fr) * 2006-05-15 2012-04-04 Merck Sharp & Dohme Corp. Composés bicycliques antidiabétiques
CA2664118A1 (fr) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Inhibiteurs de la protease
WO2016123387A1 (fr) * 2015-01-30 2016-08-04 Genentech, Inc. Composés thérapeutiques et leurs utilisations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69916425T2 (de) 1998-01-16 2005-05-19 Medivir Ab Antivirale mittel
WO1999051613A1 (fr) * 1998-04-03 1999-10-14 Medivir Ab Promedicaments de produits pharmaceutiques contenant du phosphore
SE0100733D0 (sv) * 2001-03-05 2001-03-05 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
SE0102867D0 (sv) 2001-08-28 2001-08-28 Medivir Ab Non-nucleoside reverse transcriptase inhibitors
EP1534276B1 (fr) 2002-09-05 2008-11-05 Medivir AB Inhibiteurs de la transcriptase inverse non nucleosidiques

Also Published As

Publication number Publication date
DK1701942T3 (da) 2010-04-06
EP1701942A1 (fr) 2006-09-20
IL176740A0 (en) 2006-10-31
IL176740A (en) 2011-09-27
EA200601289A1 (ru) 2006-12-29
JP2007519640A (ja) 2007-07-19
ES2337794T3 (es) 2010-04-29
BRPI0418306B8 (pt) 2021-05-25
EP1701942B1 (fr) 2009-12-09
AU2004312284A1 (en) 2005-07-21
WO2005066131A1 (fr) 2005-07-21
NZ548367A (en) 2010-06-25
AU2004312284B2 (en) 2010-08-05
EA009700B1 (ru) 2008-02-28
DE602004024584D1 (de) 2010-01-21
US7915295B2 (en) 2011-03-29
ATE451357T1 (de) 2009-12-15
AU2004312284A2 (en) 2005-07-21
BRPI0418306B1 (pt) 2018-09-18
US20080070951A1 (en) 2008-03-20
CA2550187C (fr) 2012-08-07
HK1101400A1 (en) 2007-10-18
CA2550187A1 (fr) 2005-07-21
JP4762917B2 (ja) 2011-08-31
BRPI0418306A (pt) 2007-05-02

Similar Documents

Publication Publication Date Title
IN2014CN03629A (fr)
SG150511A1 (en) Viral polymerase inhibitors
NO20161397A1 (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer
FR14C0013I2 (fr) Inhibiteurs de dipeptidyl peptidase
IL196675A0 (en) Novel hiv reverse transcriptase inhibitors
IL179398A0 (en) Dpp-ib inhibitors
GB2432609A (en) Method of expansion
ZA200703079B (en) DNA-PK Inhibitors
IL188615A0 (en) Hiv reverse transcriptase inhibitors
MY155249A (en) Combinations comprising methotrexate and dhodh inhibitors
SG148179A1 (en) Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors
EP1756092A4 (fr) Inhibiteurs novateurs de protéines rho-kinases
PL378556A1 (pl) Nienukleozydowe inhibitory odwrotnej transkryptazy
SG149855A1 (en) N-channel transistor
EP1750696B1 (fr) Inhibiteurs de protéase rétrovirale repoussant leur résistance
EP1732891A4 (fr) Inhibiteurs de la protease retrovirale inhibant la resistance
SG145667A1 (en) Chronograph watch
IL190081A0 (en) Nnrt inhibitors
SG149831A1 (en) Benzimidazole derivatives
SG149070A1 (en) Non-nucleotide reverse transcriptase inhibitors
GB0421355D0 (en) Inhibitors
EP1816194A4 (fr) Inhibiteurs de prolifération spécifique aux cellules cancéreuses
ZA200800185B (en) Hiv reverse transcriptase inhibitors
GB0421356D0 (en) Inhibitors
ZA200605395B (en) Non-nucleotide reverse transcriptase inhibitors